275 related articles for article (PubMed ID: 8380250)
1. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
Casale TB; Erger RA; Little MM
Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
Erger RA; Casale TB
Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
[TBL] [Abstract][Full Text] [Related]
3. Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species.
Carolan EJ; Casale TB
J Immunol; 1990 Oct; 145(8):2561-5. PubMed ID: 2170519
[TBL] [Abstract][Full Text] [Related]
4. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion.
Morland CM; Wilson SJ; Holgate ST; Roche WR
Am J Respir Cell Mol Biol; 1992 May; 6(5):557-66. PubMed ID: 1316135
[TBL] [Abstract][Full Text] [Related]
5. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
6. Effects of nedocromil sodium and WEB 2086 on chemoattractant-stimulated neutrophil migration through cellular and noncellular barriers.
Carolan EJ; Casale TB
Ann Allergy; 1992 Oct; 69(4):323-8. PubMed ID: 1329582
[TBL] [Abstract][Full Text] [Related]
7. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier.
Casale TB; Abbas MK; Carolan EJ
Am J Respir Cell Mol Biol; 1992 Jul; 7(1):112-7. PubMed ID: 1320901
[TBL] [Abstract][Full Text] [Related]
8. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
9. Effects of various barriers on platelet-activating factor-induced neutrophil chemotaxis.
Casale TB; Abbas MK
J Allergy Clin Immunol; 1991 Feb; 87(2):565-74. PubMed ID: 1993814
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Iwamoto I; Tomoe S; Tomioka H; Yoshida S
J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
[TBL] [Abstract][Full Text] [Related]
11. The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.
Miyagawa H; Nabe M; Hopp RJ; Okada C; Bewtra AK; Townley G
Agents Actions; 1992 Sep; 37(1-2):39-43. PubMed ID: 1456179
[TBL] [Abstract][Full Text] [Related]
12. PAF-mediated platelet adhesion to endothelial cells induced by FMLP-stimulated leukocytes.
Hirafuji M; Shinoda H
J Lipid Mediat; 1991 Nov; 4(3):347-51. PubMed ID: 1662550
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but not transmigration across IL-1 beta-treated endothelial monolayers.
Hill ME; Bird IN; Daniels RH; Elmore MA; Finnen MJ
J Immunol; 1994 Oct; 153(8):3673-83. PubMed ID: 7930587
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of degranulation from human eosinophils by platelet-activating factor.
Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ
J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Håkansson L; Venge P
J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
[TBL] [Abstract][Full Text] [Related]
17. Role of vascular cell adhesion molecule-1 and platelet-activating factor in selective eosinophil migration across vascular endothelial cells.
Sano H; Nakagawa N; Nakajima H; Yoshida S; Iwamoto I
Int Arch Allergy Immunol; 1995 Aug; 107(4):533-40. PubMed ID: 7542515
[TBL] [Abstract][Full Text] [Related]
18. Platelet activating factor is a mediator of equine neutrophil and eosinophil migration in vitro.
Foster AP; Lees P; Cunningham FM
Res Vet Sci; 1992 Sep; 53(2):223-9. PubMed ID: 1332153
[TBL] [Abstract][Full Text] [Related]
19. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines.
Okada S; Kita H; George TJ; Gleich GJ; Leiferman KM
Am J Respir Cell Mol Biol; 1997 Apr; 16(4):455-63. PubMed ID: 9115757
[TBL] [Abstract][Full Text] [Related]
20. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
